Pharmacology of a new non-steroidal anti-inflammatory agent 5-cyclohexylindan-1-carboxylic acid.
D000038:Abscess / Q000188:drug therapy; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D001168:Arthritis / Q000188:drug therapy; D001794:Blood Pressure / Q000187:drug effects; D001831:Body Temperature / Q000187:drug effects; D002264:Carboxylic Acids / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D003510:Cyclohexanes / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D004487:Edema / Q000188:drug therapy; D006099:Granuloma / Q000188:drug therapy; D007189:Indans; D007192:Indenes / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D010973:Platelet Adhesiveness / Q000187:drug effects; D051381:Rats
D000893:Anti-Inflammatory Agents; D002264:Carboxylic Acids; D003510:Cyclohexanes; D007189:Indans; D007192:Indenes; C001888:BL 2365